Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES SANOFI INDIA ZYDUS LIFESCIENCES/
SANOFI INDIA
 
P/E (TTM) x 34.2 31.0 110.4% View Chart
P/BV x 5.8 15.4 37.5% View Chart
Dividend Yield % 0.6 7.0 8.5%  

Financials

 ZYDUS LIFESCIENCES   SANOFI INDIA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
SANOFI INDIA
Dec-22
ZYDUS LIFESCIENCES/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs4957,939 6.2%   
Low Rs3195,454 5.9%   
Sales per share (Unadj.) Rs170.31,202.8 14.2%  
Earnings per share (Unadj.) Rs19.8269.5 7.3%  
Cash flow per share (Unadj.) Rs26.9287.7 9.4%  
Dividends per share (Unadj.) Rs6.00570.00 1.1%  
Avg Dividend yield %1.58.5 17.3%  
Book value per share (Unadj.) Rs173.0527.0 32.8%  
Shares outstanding (eoy) m1,012.2023.03 4,395.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.45.6 42.9%   
Avg P/E ratio x20.624.9 82.8%  
P/CF ratio (eoy) x15.123.3 65.0%  
Price / Book Value ratio x2.412.7 18.5%  
Dividend payout %30.3211.5 14.3%   
Avg Mkt Cap Rs m412,144154,224 267.2%   
No. of employees `000NANA-   
Total wages/salary Rs m24,5644,059 605.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,37427,701 622.3%  
Other income Rs m4,746730 650.1%   
Total revenues Rs m177,12028,431 623.0%   
Gross profit Rs m29,6778,349 355.5%  
Depreciation Rs m7,227419 1,724.8%   
Interest Rs m1,29917 7,641.2%   
Profit before tax Rs m25,8978,643 299.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,8782,437 241.2%   
Profit after tax Rs m20,0196,206 322.6%  
Gross profit margin %17.230.1 57.1%  
Effective tax rate %22.728.2 80.5%   
Net profit margin %11.622.4 51.8%  
BALANCE SHEET DATA
Current assets Rs m100,08236,121 277.1%   
Current liabilities Rs m55,26727,425 201.5%   
Net working cap to sales %26.031.4 82.8%  
Current ratio x1.81.3 137.5%  
Inventory Days Days50117 43.1%  
Debtors Days Days9417 549.8%  
Net fixed assets Rs m144,77612,148 1,191.8%   
Share capital Rs m1,012230 440.0%   
"Free" reserves Rs m174,14611,906 1,462.7%   
Net worth Rs m175,15812,136 1,443.3%   
Long term debt Rs m00-   
Total assets Rs m244,94048,279 507.3%  
Interest coverage x20.9509.4 4.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.6 122.7%   
Return on assets %8.712.9 67.5%  
Return on equity %11.451.1 22.3%  
Return on capital %15.571.4 21.8%  
Exports to sales %39.214.1 278.2%   
Imports to sales %11.914.6 81.8%   
Exports (fob) Rs m67,5773,904 1,731.0%   
Imports (cif) Rs m20,5444,037 508.9%   
Fx inflow Rs m67,5773,904 1,731.0%   
Fx outflow Rs m20,5444,037 508.9%   
Net fx Rs m47,033-133 -35,429.8%   
CASH FLOW
From Operations Rs m26,8883,987 674.4%  
From Investments Rs m11,7126,509 179.9%  
From Financial Activity Rs m-44,004-15,827 278.0%  
Net Cashflow Rs m-5,338-5,331 100.1%  

Share Holding

Indian Promoters % 75.0 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 18.0 28.8 62.6%  
FIIs % 5.0 6.3 79.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 39.6 63.2%  
Shareholders   306,495 62,870 487.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Sanofi India Share Price Performance

Period Cadila Healthcare Sanofi India S&P BSE HEALTHCARE
1-Day 0.57% 2.06% 1.18%
1-Month 7.77% -8.09% -0.75%
1-Year 107.52% 44.45% 61.82%
3-Year CAGR 32.30% 0.97% 18.16%
5-Year CAGR 24.52% 7.07% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

Sanofi India paid Rs 570.0, and its dividend payout ratio stood at 211.5%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.